Upper Gastrointestinal Endoscopy in HIV-infected Individuals

NCT07425067 · tracked via the Priya Life Science Belgium tracker

Sponsor

Centre Hospitalier Universitaire Saint Pierre

Phase

Observational

Started

2004-01-01

Last updated

2026-02-20

Condition(s) studied

HIV

Investigational drug(s) / intervention(s)

Gastroscopy

Study summary

The aim of this registry is to collect prospectively demographic characteristics and upper gastrointestinal endoscopy diagnoses over a long-term period, in people living with HIV, undergoing upper gastrointestinal endoscopy

Eligibility

Sex

ALL

Min age

18 Years

Max age

99 Years

Healthy volunteers

Inclusion criteria: adults aged 18 years or older; first upper gastrointestinal endoscopy; written informed consent. Exclusion criteria: inability to provide informed consent or refusal.

Primary outcome measure(s)

Outcome: demographic, clinical characteristics; endoscopy findings; and pathology diagnoses — 2026

Trial sites (1)

Facility	City	Region	Status
CHU Saint Pierre	Brussels	Belgium	Recruiting

More Centre Hospitalier Universitaire Saint Pierre trials in Belgium

Effects of Thyroidectomy on Obstructive Sleep Apnea in Patients Suffering From Goiters Recruiting

A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty Recruiting

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients Recruiting

Dreams or Implicite Memorization Under OFA Recruiting

Changes in Body Fat and Morphologic Characteristics Associated With OSA Resolution After Bariatric Surgery Recruiting

Other trials for the same condition

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV Enrolling by invitation

A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty Recruiting

Sequential Analysis Before and After Treatment Initiation to Unravel the Role of Naturally Occurring Extracellular Vesicles in HIV Infection Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy Active, not recruiting

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial. Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07425067 on ClinicalTrials.gov ↗ ← All trials in Belgium